CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websiteadimab.com
CategoryBioTech
Phone(603) 727-7107
Emailinfo@adimab.com
Employees60
Founded5/07
Descriptionmonoclonal antibody discovery platform

Offices

Lebanon, USA
16 Cavendish Court
Lebanon, NH, 03766
USA

People

VP, Head, Business Development
VP & Head, Computational Biology
Board Director
Board Director
Board Director
Board Director
Director, Antibody Discovery & Optimization
Director, Open Innovation
Show All People

Former People

Group Leader
Senior Scientist I
Scientist II
Scientist

Funding

TOTAL $39.7M
FUNDING TOTAL $39.7M
Series A, 7/07
$400k
Venture Round, 7/07
$2.38k
Series A, 9/07
Polaris Partners
SV Life Sciences
$5.9M
Series B, 4/08
$3.18M
Series C, 11/08
OrbiMed Advisors
Borealis Ventures
Polaris Partners
SV Life Sciences
$4M
Series D, 1/10
Google Ventures
OrbiMed Advisors
Borealis Ventures
Polaris Partners
SV Life Sciences
$8.2M
Venture Round, 12/10
$4M
Series F, 4/12
Venture Round, 4/12
Google Ventures
Polaris Partners
SV Life Sciences
$14M

Tags

Adimab

Adimab’s integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

Recent Milestones

  • Dollar
    Adimab received $14M in Venture Round funding. (4/3/12)
    Posted 4/3/12 at 8:04pm via fiercebiotech.com
  • Dollar
    Adimab received () in Series F funding. (4/2/12)
    Posted 4/2/12 at 6:36pm via adimab.com
  • Dollar
    Adimab received $4M in Venture Round funding. (12/1/10)
    Posted 12/1/10 at 10:57pm via masshightech.com
  • Dollar
    Adimab received $8.2M in Series D funding. (1/22/10)
    Posted 1/22/10 at 4:28pm via onbiovc.com
  • Dollar
    Adimab received $4M in Series C funding. (11/20/08)
    Posted 1/22/10 at 4:28pm via adimab.com
  • Dollar
    Adimab received $3.18M in Series B funding. (4/1/08)
    Posted 2/24/10 at 3:59pm via sec.gov
  • Dollar
    Adimab received $5.9M in Series A funding. (9/21/07)
    Posted 2/24/10 at 3:57pm via sec.gov
  • Dollar
    Adimab received $2.38k in Venture Round funding. (7/16/07)
    Posted 2/24/10 at 3:57pm via sec.gov
  • Dollar
    Adimab received $400k in Series A funding. (7/1/07)
    Posted 2/24/10 at 3:57pm via sec.gov
  • Check
    Adimab added K. Dane Wittrup as Co - Founder, Office Of The CSO & Chairman, SAB. (1/1/07)
    Posted 6/4/13 at 10:08pm
  • Check
    Adimab added Tillman Gerngross as Co - Founder & CEO & Board Director.
    Posted 5/14/11 at 6:18pm

Videos

Screenshots

Sources

  1. SEC D (sec.gov) [edit]
  2. SEC D (sec.gov) [edit]
  3. SEC D (sec.gov) [edit]
  4. SEC D (sec.gov) [edit]
  5. Adimab, Inc. Announces Series C Financing (adimab.com) [edit]
  6. Adimab, Inc.: Series D $8.2M (onbiovc.com) [edit]
  7. NH biotech startup Adimab attracts $4M funding (masshightech.com) [edit]
  8. Adimab Completes Series F Financing - Acquires New Research Facility to Accommodate Growth (adimab.com) [edit]
  9. Google contributes to $14M round for fast-growing Adimab (fiercebiotech.com) [edit]
Edit This Page
Last Edited 6/5/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy